ConductScience.org, home

Comparison · NCT03022526-45c3ec8a

Combined Spinal Epidural (CSE) vs Epidural: Number of Participants Currently Breastfeeding at 2 Days Postpartum (Yes/No)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Combined Spinal Epidural (CSE) vs Epidural: Number of Participants Currently Breastfeeding at 2 Days Postpartum (Yes/No). Trial comparisons, record NCT03022526-45c3ec8a. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03022526-45c3ec8a

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.880.70.958wilson
Risk in group 20.6430.4580.793wilson
Risk difference, group 1 minus group 20.2370.003120.438newcombe hybrid score
Risk ratio, group 1 over group 21.3711.87log
Odds ratio, group 1 over group 24.070.97217.1log
Number needed to treat, for one more participant with the outcome on Combined Spinal Epidural (CSE) than on Epidural4.222.29320from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Combined Spinal Epidural (CSE)
intrathecal bupivacaine 2.5mg + fentanyl 15mcg followed by infusion (PCEA): bupivacaine 0.083% with fentanyl 2mcg/mL: basal 8mL/hr, demand 8mL, 2 boluses per hour allowed, total maximum hourly allowance 24mL~CSE~Bupivacaine / fentaNYL
2225OG000
Group 2Epidural
epidural bupivacaine 0.083% + fentanyl 2mcg/mL (8mL) followed by fentanyl 100mcg (2mL); follwed by infusion (PCEA): bupivacaine 0.083% with fentanyl 2mcg/mL: basal 8mL/hr, demand 8mL, 2 boluses per hour allowed, total maximum hourly allowance 24mL~Epidural~Bupivacaine / fentaNYL
1828OG001

Outcome

Type
SECONDARY
Title
Number of Participants Currently Breastfeeding at 2 Days Postpartum (Yes/No)
Description
Self-completed questionnaire, electronically completed. Results represent the percentage of each arm currently breastfeeding at this time point.
Time frame
2 Days Postpartum
Population
This population includes all participants who completed the electronically administered breastfeeding form at the postpartum day 2 timepoint.

Source ClinicalTrials.gov

Trial

Title
CSE v. Epidural for Postpartum Depression
NCT number
NCT03022526
Phases
NA
Conditions
Depression, Postpartum, Labor Pain
Interventions
CSE, Epidural, Bupivacaine / fentaNYL
Lead sponsor
Grace Lim, MD, MS
Results first posted
2020-08-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03022526-45c3ec8a